Pharmacodynamic model of PARP1 inhibition and global sensitivity analyses can lead to cancer biomarker discovery https://www.biorxiv.org/content/10.1101/2023.02.08.527527v1?med=mas
Pharmacodynamic model of PARP1 inhibition and global sensitivity analyses can lead to cancer biomarker discovery https://www.biorxiv.org/content/10.1101/2023.02.08.527527v1?med=mas